In addition, we demonstrated that knockdown of GRK5 inhibited NSCLC cell proliferation, migration in vitro, and xenograft tumor formation in vivo by promoting cell cycle arrest at G2/M phase and inducing cellular apoptosis. Here, GRK5 is linked to neoplasm.